NEW YORK--(BUSINESS WIRE)--AXA Equitable Holdings, Inc. (the “Company”) announced the pricing of $800 million aggregate principal amount of 3.900% Senior Notes due 2023, $1.5 billion aggregate principal amount of 4.350% Senior Notes due 2028 and $1.5 billion aggregate principal amount of 5.000% Senior Notes due 2048 (together, the “Notes”). The Company intends to use the net proceeds from the sale of the Notes, together with available cash at its subsidiary AXA Equitable Life and the proceeds of borrowings under the Company’s term loan agreements, to (i) repay certain financing provided by the Company’s parent company AXA S.A. and its affiliates, (ii) terminate or reduce the commercial paper program of AXA Financial, Inc., a wholly-owned subsidiary of the Company, and (iii) purchase units of limited partnership interests in AllianceBernstein L.P. from AXA S.A. and its affiliates, which when effected will complete the Company’s pre-IPO reorganization transactions.
The Notes were offered in a private offering exempt from the registration requirements of the United States Securities Act of 1933, as amended (the “Securities Act”). The Notes were offered only to qualified institutional buyers pursuant to Rule 144A and to certain persons outside the United States pursuant to Regulation S, each under the Securities Act. The Notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws.
This press release is for informational purposes only and is not an offer to sell or purchase nor the solicitation of an offer to sell or purchase securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any person to whom, such an offer, solicitation or sale would be unlawful.